PMHC – eVolve-1 / OZM-060

Trial Description: 
A Proof of Concept, Multi-centre, Clinical Trial of the Combination Cediranib-Olaparib at the Time of Disease Progression on PARP Inhibitor in Ovarian Cancer
Lead Cooperative Group: 
Disease Site: 
Ovarian
Trial Status: 
Closed to Recruitment
Contact person: